Common (1% to 10%): Vulvovaginal pruritus, leukorrhea, vaginal hemorrhage, vaginal discharge, vaginal discomfort, menopause symptoms, breakthrough bleeding or spotting, dysmenorrhea, breast swelling, menorrhagia, metrorrhagia, endometrial hyperplasia Uncommon (0.1% to 1%): Urinary problems Rare (less ...
Common (1% to 10%): Vulvovaginal pruritus, leukorrhea, vaginal hemorrhage, vaginal discharge, vaginal discomfort, menopause symptoms, breakthrough bleeding or spotting, dysmenorrhea, breast swelling, menorrhagia, metrorrhagia, endometrial hyperplasia Uncommon (0.1% to 1%): Urinary problems Rare (less ...
Are severe menopause symptoms a bellwether of bone health?Women with more severe vasomotor symptoms and night sweats may be at risk of having poorer bone health, according to a prospective observational study.doi:http://contemporaryobgyn.modernmedicine.com/node/392888M. Hester...
Bayer recently announced that a New Drug Application (NDA) for the investigational compound elinzanetant has been submitted to the US FDA for the treatment of moderate to severe vasomotor symptoms (VMS, also known as hot flashes) associated with menopause. The submission is...
Fezolinetant for Moderate to Severe Vasomotor Symptoms Associated with Menopause: Effectiveness and Value; Final Evidence ReportAuthor(s): F Beaudoin, R McQueen, A. Wright Publication date: 2023 Journal: Institute for Clinical and Economic Review...
My menopause will soon be over, and I’m afraid of getting osteoporosis. I watched my mother suffer for many years, and I am afraid that will happen to me too. She had severe osteoporosis, and her bones were so fragile, the slightest pressure could break them. She had several fractures...
For those going through menopause,treatments for sleep disordersand severe insomnia focus on resolving the fundamental problem, hormonal imbalance. Implementing lifestyle changes that include an optimized diet rich in phytoestrogens and healthy habits - regular sleep schedule, relaxation techniques, etc. -...
Women undergo a similar decline in lean mass, but additionally demonstrate a more pronounced increase in fat mass, particularly at menopause age. Consequently, our findings suggest a higher prevalence of sarcopenic obesity (SO) among women, implying that women with obesity may encounter a greater ...
“Basically, all menopause symptoms were made worse with the exception of generalized anxiety. We found no connection there,” says Emily Oken, MD, MPH, one of the study authors and the principal investigator of the Project Viva cohort at the department of population medicine at Harvard Medical...
Fezolinetant is one of the first non-hormonal neurokinin 3 receptor antagonists in development for the treatment of vasomotor symptoms due to menopause. This study investigated the safety and efficacy of fezolinetant for the treatment of moderate-to-severe vasomotor symptoms associated with menopause....